- Stocks
- Healthcare
- NASDAQ: OPK

Price (delayed)

$3.69

Market cap

$2.51B

P/E Ratio

33.55

Dividend/share

N/A

EPS

$0.11

Enterprise value

$2.69B

Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and

The company's revenue has surged by 98% YoY and by 8% QoQ

The gross profit has soared by 75% YoY

The net income has soared by 135% year-on-year but it is down by 41% since the previous quarter

Opko Health's EPS has soared by 133% YoY but it has decreased by 42% from the previous quarter

Opko Health's gross margin has decreased by 11% YoY and by 6% from the previous quarter

What are the main financial stats of OPK

Market
Valuations
Earnings

Shares outstanding

681.16M

Market cap

$2.51B

Enterprise value

$2.69B

Price to earnings (P/E)

33.55

Price to book (P/B)

1.42

Price to sales (P/S)

1.25

EV/EBIT

24.93

EV/EBITDA

14.19

EV/Sales

1.41

Revenue

$1.91B

EBIT

$107.89M

EBITDA

$189.49M

Free cash flow

$73.47M

Per share
Balance sheet
Liquidity

EPS

$0.11

Free cash flow per share

$0.11

Book value per share

$2.6

Revenue per share

$2.95

TBVPS

$2.01

Total assets

$2.42B

Total liabilities

$679.07M

Debt

$241.87M

Equity

$1.74B

Working capital

$243.05M

Debt to equity

0.14

Current ratio

1.8

Quick ratio

1.09

Net debt/EBITDA

0.93

Margins
Efficiency
Dividend

EBITDA margin

9.9%

Gross margin

34.7%

Net margin

3.7%

Operating margin

6%

Return on assets

2.9%

Return on equity

4.2%

Return on invested capital

9.4%

Return on capital employed

5.1%

Return on sales

5.6%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Opko Health stock price performed over time

Intraday

-0.27%

1 week

-0.81%

1 month

-2.89%

1 year

-13.58%

YTD

-6.58%

QTD

1.1%

How have Opko Health's revenue and profit performed over time

Revenue

$1.91B

Gross profit

$662.4M

Operating income

$115.3M

Net income

$70.91M

Gross margin

34.7%

Net margin

3.7%

The operating income has soared by 170% YoY but it has contracted by 16% from the previous quarter

OPK's operating margin has soared by 135% year-on-year but it is down by 22% since the previous quarter

The net income has soared by 135% year-on-year but it is down by 41% since the previous quarter

The net margin has soared by 118% YoY but it has decreased by 46% QoQ

What is Opko Health's growth rate over time

What is Opko Health stock price valuation

P/E

33.55

P/B

1.42

P/S

1.25

EV/EBIT

24.93

EV/EBITDA

14.19

EV/Sales

1.41

Opko Health's EPS has soared by 133% YoY but it has decreased by 42% from the previous quarter

The P/B is 11% below the last 4 quarters average of 1.6

Opko Health's equity has increased by 10% YoY and by 2.7% QoQ

The company's revenue has surged by 98% YoY and by 8% QoQ

The P/S is 46% below the 5-year quarterly average of 2.3 and 26% below the last 4 quarters average of 1.7

How efficient is Opko Health business performance

OPK's ROIC has soared by 160% year-on-year but it is down by 33% since the previous quarter

The ROE has soared by 134% YoY but it has decreased by 42% QoQ

Opko Health's ROS has soared by 133% YoY but it has decreased by 38% from the previous quarter

The ROA has soared by 133% YoY but it has contracted by 42% from the previous quarter

What is OPK's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for OPK.

How did Opko Health financials performed over time

Opko Health's current ratio has increased by 40% YoY and by 22% from the previous quarter

Opko Health's quick ratio has increased by 30% YoY and by 8% from the previous quarter

The debt is 86% lower than the equity

The debt to equity is down by 18% since the previous quarter and by 18% year-on-year

The debt has decreased by 15% QoQ and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.